Allegro MicroSystems Files 8-K
Ticker: ALGM · Form: 8-K · Filed: Jan 6, 2025 · CIK: 866291
| Field | Detail |
|---|---|
| Company | Allegro Microsystems, Inc. (ALGM) |
| Form Type | 8-K |
| Filed Date | Jan 6, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $375 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financial-statements
Related Tickers: ALGM
TL;DR
Allegro MicroSystems filed an 8-K on Jan 6, 2025, mostly routine stuff.
AI Summary
On January 6, 2025, Allegro MicroSystems, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond routine disclosures were detailed in the provided excerpt.
Why It Matters
This filing indicates routine corporate disclosures and potential updates to financial statements for Allegro MicroSystems, Inc.
Risk Assessment
Risk Level: low — The provided excerpt of the 8-K filing does not contain any specific material events or financial information that would indicate a high or medium risk.
Key Players & Entities
- Allegro MicroSystems, Inc. (company) — Registrant
- January 6, 2025 (date) — Date of earliest event reported
- 001-39675 (company) — Commission File Number
- 46-2405937 (company) — IRS Employer Identification No.
- 955 Perimeter Road, Manchester, New Hampshire 03103 (location) — Address of Principal Executive Offices
- (603) 626-2300 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is January 6, 2025.
What is Allegro MicroSystems, Inc.'s Commission File Number?
Allegro MicroSystems, Inc.'s Commission File Number is 001-39675.
Where is Allegro MicroSystems, Inc.'s principal executive office located?
Allegro MicroSystems, Inc.'s principal executive office is located at 955 Perimeter Road, Manchester, New Hampshire 03103.
Does this filing indicate any specific new material events or financial results?
Based on the provided excerpt, this filing primarily concerns routine disclosures and does not detail specific new material events or financial results.
Filing Stats: 1,031 words · 4 min read · ~3 pages · Grade level 13 · Accepted 2025-01-06 07:08:41
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share ALGM The Nasdaq Stock Mar
- $375 million — h is currently expected to consist of a $375 million U.S. dollar-denominated first lien term
Filing Documents
- algm-20250106.htm (8-K) — 52KB
- 0000950170-25-001662.txt ( ) — 161KB
- algm-20250106.xsd (EX-101.SCH) — 25KB
- algm-20250106_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 6, 2025, Allegro MicroSystems, Inc. (the " Company ") launched a process to refinance in full the Company's existing term loans with a new tranche of term loans (the " Refinancing and Repricing Facility "), which is currently expected to consist of a $375 million U.S. dollar-denominated first lien term facility. Morgan Stanley Senior Funding, Inc. is expected to serve as administrative agent for the Refinancing and Repricing Facility. Terms of the potential refinancing and the Refinancing and Repricing Facility will be disclosed upon the completion of the transaction. The proposed refinancing is subject to market and other conditions, and there can be no assurance that it will be completed on favorable terms or at all. The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the " Securities Act "), or the Exchange Act, except as expressly set forth by specific reference in such filing.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act, and Section 21E of the Exchange Act. All statements, other than statements of historical facts, contained in this Current Report on Form 8-K, including statements regarding the Refinancing and Repricing Facility, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as "aim," "may," "will," "should," "expect," "exploring," "plan," "anticipate," "could," "intend," "target," "project," "would," "contemplate," "believe," "estimate," "predict," "potential," "seek," or "continue" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements. Forward-looking statements are based on our management's current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description Exhibit 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLEGRO MICROSYSTEMS, INC. Date: January 6, 2025 By: /s/ Derek P. D'Antilio Derek P. D'Antilio Executive Vice President, Chief Financial Officer and Treasurer